Study finds Mounjaro ‘significantly more’ effective than Ozempic for weight loss

Study finds Mounjaro ‘significantly more’ effective than Ozempic for weight loss

THE SIGNAL

Overweight and obese adults using popular diabetes medications to suppress their appetites are “significantly more likely” to shed pounds with Eli Lilly’s Mounjaro than with Novo Nordisk’s Ozempic, a new study has found, a result that could have major implications for one of the hottest new markets in the pharmaceutical field.
Writing Monday in JAMA Internal Medicine, seven medical experts compared the health records of 18,386 adults with excessive body mass indexes who used one of the two Type 2 diabetes drugs in c …

Leave a Reply

Your email address will not be published. Required fields are marked *

Send this to a friend